SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cur… […]
– DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc.- Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol “KTRA”
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharm… […]
CARLSBAD, Calif., Aug. 20, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled “Devices and Methods f… […]
Oral Presentation to Highlight New Efficacy Data Measured at Week 16 and Additional Week 12 Efficacy Data Stratified by Baseline Characteristics and Risk Factors
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKT… […]
SAN DIEGO, Aug. 18, 2020 /PRNewswire/ — Inhibrx, Inc. (“Inhibrx”) (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, today announced the pricing of its initial pub… […]
Expands Company’s patent portfolio and marks another step in pursuit of worldwide intellectual property protection for proprietary Primer-Switch technology used to detect rare events such as cancer biomarkers found in tissue and liquid biopsies
SAN … […]
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic … […]
CARLSBAD, Calif., Aug. 14, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020.
Business hig… […]
Completion of Dosing in Phase 1 Multiple Ascending Dose Study (“MAD”) of RGLS4326 in Healthy Volunteers for Autosomal Dominant Polycystic Kidney Disease (“ADPKD”)FDA Orphan Designation of RGLS4326 for ADPKDAppointment of Denis Drygin, Ph.D., as Chief S… […]
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines
SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its fi… […]
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ — Biocom, the association representing the California life science industry, today announced the appointment of Randy Piper as managing director for the Biocom Purchasing Group, a subsidiary of Biocom that acce… […]
eCLIP technology solved key problem in matching hundreds of RNA binding proteins to the instruction signals within the RNA code to uncover how RNA binding proteins regulate gene expression
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ — Eclipse Bioinno… […]
Mr. Mottiwala Brings over 20 Years of Biopharmaceutical Experience to Growing Tarsus Leadership Team
ORANGE COUNTY, Calif., Aug. 11, 2020 /PRNewswire/ — Tarsus Pharmaceuticals, a late clinical-stage biopharmaceutical company, today announced the app… […]
Successful completion of $300 million initial public offering; cash and cash equivalents of over $350 million as of June 30, 2020Strengthened leadership team with additions of Michael MacLean as Chief Financial Officer and Jae Kim, M.D., as Chief Medic… […]
– Reports First Quarter of Expected Sustainable Profitability and Maintains 2020 Guidance of $230 to $245 Million in Revenues and $0.60 to $0.75 Earnings Per Share — Two U.S. FDA Approvals and One EMA Approval Received by Partners for Products Utilizi… […]
SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results and a corporate update for the second quarter ended June 30, 2020.
“Mirati is working to d… […]
CARLSBAD, Calif., Aug. 6, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that it will host a business update conference call and live webcast on Tuesday, August 18, 2020 at 4:30 p.m. Eastern… […]
Technology, expertise from UK’s Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy
SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — A biopharmaceutical company repurposing nafamostat, a generic remedy for… […]
LA JOLLA, Calif., Aug. 6, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan, Pr… […]
SAN DIEGO, Aug. 5, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best–in-class treatments to address some of the most important unmet p… […]
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — Prometheus Biosciences, Inc., (“Prometheus”) a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagno… […]
CARLSBAD, Calif., Aug. 4, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, wit… […]
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, President and Chief Executive Officer, will present a… […]
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — HUYA Bioscience International (HUYABIO
®
), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, … […]
– Advancing Precommercial Activities in Preparation for Phexxi(TM) Commercial Launch in September 2020 — Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea on Track for Q4 2020 Initiation — Management to Host Conference Call Tu… […]
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI”), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive officer of… […]
LAGUNA HILLS, Calif., Aug. 3, 2020 /PRNewswire/ — Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™… […]
SAN DIEGO, Aug. 3, 2020 /PRNewswire/ — Microbiologics announced today that it has recently completed renovations of the virology services laboratory in its San Diego location. With completion of the renovation, Microbiologics has expanded its custo… […]
SAN DIEGO, Aug. 3, 2020 /PRNewswire/ — Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced that Dr. Jeanne Loring, co-founder and Chief Scientifi… […]
Copyright © 2021 Biotech Networks, LLC
